Patients suffering from epilepsy have both short- (eg, seizure control) and long-term (eg, uncontrolled comorbidities and low quality of life [QOL]) unmet medical needs. In addition to regular disease activity monitoring, appropriate management of comorbid conditions, addressing the individual needs of special populations, including female and elderly patients, and QOL issues are important components of care for patients with epilepsy. The advancement of adjunctive therapies also requires discussion since newer therapies with different mechanisms of action may be more effective, and therefore could eliminate the need for multiple anti-epilepsy drug therapy in patients with epilepsy. Through education, practitioners may be able to achieve better patient outcomes in these areas of care.
This educational initiative has been designed for neurologists and internal medicine physicians involved in the management of patients with epilepsy.
Upon completion of this educational activity, participants should be able to:
Utilize strategies to identify important comorbidities of epilepsy and ameliorate their impact on patient quality of life
Identify unmet medical needs of special populations, including female and elderly patients, with epilepsy
Describe the importance of optimizing treatment of focal seizures early in the epilepsy treatment trajectory
Conflict Of Interest Disclosure Policy
Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Gregory K. Bergey, MD Professor of Neurology Director, Johns Hopkins Epilepsy Center The Johns Hopkins University Baltimore, MD
Dr. Bergey has no real or apparent conflicts of interest to report.
Robert Fisher, MD, PhD Maslah Saul MD Professor of Neurology and Neurological Sciences Stanford University Palo Alto, CA
Dr. Fisher discloses the following: Consulting Fees: Engage Therapeutics Ownership Interest: Avails Medical, Cerebral Therapeutics, SmartWatch, Zeto
Accredited Provider Disclosure
Patima Tanapat, PhD, has no real or apparent conflicts of interest to disclose.
AMA PRA Category 1 Credit(s)TM
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.
Integrity Continuing Education designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and UCB do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Inc. and UCB. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.
There are no fees for participating and receiving CME credit for this activity. During the period of October 2, 2017 through October 2, 2018, participants must:
Read the learning objectives and faculty disclosures
Complete the pre-test
Study the educational activity
Complete the post-test and the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 100%.
For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or email@example.com.